RATIONALE: To determine vascular signaling pathways involved in inhaled air pollution (vehicular engine emission) exposure-induced exacerbation of atherosclerosis that are associated with onset of clinical cardiovascular events. OBJECTIVES: To elucidate the role of oxidized low-density lipoprotein (oxLDL) and its primary receptor on endothelial cells, the lectin-like oxLDL receptor (LOX-1), in regulation of endothelin-1 expression and matrix metalloproteinase activity associated with inhalational exposure to vehicular engine emissions. METHODS: Atherosclerotic apolipoprotein E knockout mice were exposed by inhalation to filtered air or mixed whole engine emissions (250 μg particulate matter [PM]/m(3) diesel + 50 μg PM/m(3) gasoline exhausts) 6 h/d for 7 days. Concurrently, mice were treated with either mouse IgG or neutralizing antibodies to LOX-1 every other day. Vascular and plasma markers of oxidative stress and expression proatherogenic factors were assessed. In a parallel study, healthy human subjects were exposed to either 100 μg PM/m(3) diesel whole exhaust or high-efficiency particulate air and charcoal-filtered "clean" air (control subjects) for 2 hours, on separate occasions. MEASUREMENTS AND MAIN RESULTS: Mixed emissions exposure increased oxLDL and vascular reactive oxygen species, as well as LOX-1, matrix metalloproteinase-9, and endothelin-1 mRNA expression and also monocyte/macrophage infiltration, each of which was attenuated with LOX-1 antibody treatment. In a parallel study, diesel exhaust exposure in volunteer human subjects induced significant increases in plasma-soluble LOX-1. CONCLUSIONS: These findings demonstrate that acute exposure to vehicular source pollutants results in up-regulation of vascular factors associated with progression of atherosclerosis, endothelin-1, and matrix metalloproteinase-9, mediated through oxLDL-LOX-1 receptor signaling, which may serve as a novel target for future therapy.
RATIONALE: To determine vascular signaling pathways involved in inhaled air pollution (vehicular engine emission) exposure-induced exacerbation of atherosclerosis that are associated with onset of clinical cardiovascular events. OBJECTIVES: To elucidate the role of oxidized low-density lipoprotein (oxLDL) and its primary receptor on endothelial cells, the lectin-like oxLDL receptor (LOX-1), in regulation of endothelin-1 expression and matrix metalloproteinase activity associated with inhalational exposure to vehicular engine emissions. METHODS:Atheroscleroticapolipoprotein E knockout mice were exposed by inhalation to filtered air or mixed whole engine emissions (250 μg particulate matter [PM]/m(3) diesel + 50 μg PM/m(3) gasoline exhausts) 6 h/d for 7 days. Concurrently, mice were treated with either mouse IgG or neutralizing antibodies to LOX-1 every other day. Vascular and plasma markers of oxidative stress and expression proatherogenic factors were assessed. In a parallel study, healthy human subjects were exposed to either 100 μg PM/m(3) diesel whole exhaust or high-efficiency particulate air and charcoal-filtered "clean" air (control subjects) for 2 hours, on separate occasions. MEASUREMENTS AND MAIN RESULTS: Mixed emissions exposure increased oxLDL and vascular reactive oxygen species, as well as LOX-1, matrix metalloproteinase-9, and endothelin-1 mRNA expression and also monocyte/macrophage infiltration, each of which was attenuated with LOX-1 antibody treatment. In a parallel study, diesel exhaust exposure in volunteer human subjects induced significant increases in plasma-soluble LOX-1. CONCLUSIONS: These findings demonstrate that acute exposure to vehicular source pollutants results in up-regulation of vascular factors associated with progression of atherosclerosis, endothelin-1, and matrix metalloproteinase-9, mediated through oxLDL-LOX-1 receptor signaling, which may serve as a novel target for future therapy.
Authors: Thomas Kampfrath; Andrei Maiseyeu; Zhekang Ying; Zubair Shah; Jeffrey A Deiuliis; Xiaohua Xu; Nisharahmed Kherada; Robert D Brook; Kongara M Reddy; Nitin P Padture; Sampath Parthasarathy; Lung Chi Chen; Susan Moffatt-Bruce; Qinghua Sun; Henning Morawietz; Sanjay Rajagopalan Journal: Circ Res Date: 2011-01-27 Impact factor: 17.367
Authors: R de Nooijer; C J N Verkleij; J H von der Thüsen; J W Jukema; E E van der Wall; Thüsen J C van Berkel; A H Baker; E A L Biessen Journal: Arterioscler Thromb Vasc Biol Date: 2005-11-23 Impact factor: 8.311
Authors: Qi Chen; Steven E Reis; Candace Kammerer; Wendy Y Craig; Sue E LaPierre; Erin Luedecking Zimmer; Dennis M McNamara; Daniel F Pauly; Barry Sharaf; Richard Holubkov; C Noel Bairey Merz; George Sopko; Franklin Bontempo; M Ilyas Kamboh Journal: Circulation Date: 2003-06-16 Impact factor: 29.690
Authors: Tina E Brinkley; Noriaki Kume; Hirokazu Mitsuoka; Michael D Brown; Dana A Phares; Robert E Ferrell; Toru Kita; James M Hagberg Journal: Exp Physiol Date: 2008-05-09 Impact factor: 2.969
Authors: Christen L Mumaw; Shannon Levesque; Constance McGraw; Sarah Robertson; Selita Lucas; Jillian E Stafflinger; Matthew J Campen; Pamela Hall; Jeffrey P Norenberg; Tamara Anderson; Amie K Lund; Jacob D McDonald; Andrew K Ottens; Michelle L Block Journal: FASEB J Date: 2016-02-10 Impact factor: 5.191
Authors: Sarah Robertson; Elizabeth S Colombo; Selita N Lucas; Pamela R Hall; Maria Febbraio; Michael L Paffett; Matthew J Campen Journal: Toxicol Sci Date: 2013-05-06 Impact factor: 4.849
Authors: Jeremy B Brower; Melanie Doyle-Eisele; Benjamin Moeller; Steven Stirdivant; Jacob D McDonald; Matthew J Campen Journal: Inhal Toxicol Date: 2016-03-28 Impact factor: 2.724
Authors: Jonathan C Schisler; Sarah M Ronnebaum; Michael Madden; Meghan Channell; Matthew Campen; Monte S Willis Journal: Inhal Toxicol Date: 2015-05-05 Impact factor: 2.724
Authors: Xiaoquan Rao; Jixin Zhong; Andrei Maiseyeu; Bhavani Gopalakrishnan; Frederick A Villamena; Lung-Chi Chen; Jack R Harkema; Qinghua Sun; Sanjay Rajagopalan Journal: Circ Res Date: 2014-09-03 Impact factor: 17.367